Detalhe da pesquisa
1.
Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from Türkiye.
Future Oncol
; 20(15): 1031-1045, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014519
2.
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.
J Oncol Pharm Pract
; : 10781552241241004, 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38613329
3.
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(9): 989-1001, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591293
4.
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.
Lancet Oncol
; 24(1): 77-90, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493792
5.
Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer.
Curr Issues Mol Biol
; 45(10): 7803-7812, 2023 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37886935
6.
Patient-reported outcomes with cemiplimab monotherapy for first-line treatment of advanced non-small cell lung cancer with PD-L1 of ≥50%: The EMPOWER-Lung 1 study.
Cancer
; 129(1): 118-129, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36308296
7.
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study.
Acta Oncol
; 62(4): 381-390, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37083566
8.
An experimental study: the effect of S. boulardii on abemaciclibinduced diarrhea.
Turk J Med Sci
; 53(1): 51-57, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945921
9.
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Br J Cancer
; 126(4): 569-575, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34621044
10.
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial.
Lancet
; 397(10274): 592-604, 2021 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33581821
11.
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS).
Gastric Cancer
; 25(3): 586-597, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997449
12.
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey.
Future Oncol
; 18(29): 3267-3276, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040321
13.
Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma.
Support Care Cancer
; 30(3): 2131-2139, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34677649
14.
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
N Engl J Med
; 379(1): 54-63, 2018 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29972759
15.
Investigation of the relationship between GSTM1 gene variations and serum trace elements, plasma malondialdehyde levels in patients with colorectal cancer.
Mol Biol Rep
; 48(10): 6911-6921, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498162
16.
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.
Future Oncol
; 17(35): 4861-4869, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726480
17.
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study.
J Oncol Pharm Pract
; 27(7): 1623-1630, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33050804
18.
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 21(1): 105-120, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753727
19.
Evaluating sun protection behaviors and skin self-examination practices among the family members of melanoma patients in Turkey: A cross-sectional survey study.
Dermatol Ther
; 33(6): e14268, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32882080
20.
Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study.
Int J Clin Oncol
; 25(10): 1757-1762, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591963